Recent Company News

• 05:17 AM ET Jun 30, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (74 total)

• 08:31 AM ET Jun 29, 2026
  

  StreetAccount Themes Headlines (29-Jun)

• 06:05 AM ET Jun 29, 2026
  

  StreetAccount Macro Headlines:

• 01:17 AM ET Jun 29, 2026
  

  Sandoz Group announces FDA accepts company's applications for proposed in-house development of generic tirzepatide GLP-1s (CHF 71.88, 0.00)

• 06:27 AM ET Jun 25, 2026
  

  Shanghai Henlius Biotech doses first patient in US phase 1 clinical study of HLX13 for treatment of hepatocellular carcinoma (HK$59.35, 0.00)

• 07:13 AM ET Jun 23, 2026
  

  Zhejiang Huahai Pharmaceutical guides FY net income to increase by CNY82.0M due to legal fees received from Sandoz AG (CNY 14.69, 0.00)

• 08:18 AM ET Jun 17, 2026
  

  StreetAccount European Reads

• 08:04 PM ET May 31, 2026
  

  Sandoz Group calls on EU to do more to prevent antibiotics industry from being decimated by cheap Chinese imports - FT, citing CEO (CHF 65.60, 0.00)

• 02:14 AM ET May 28, 2026
  

  Sandoz Group confirms it has filed draft anti‑dumping complaint to the European Commission concerning Chinese imports of Amoxicillin API (CHF 64.52, 0.00)

• 02:30 AM ET May 27, 2026
  

  AGCM (Italian Competition Authority) launches investigation into Biogen over possible abuse of dominant position ($193.08, 0.00)